Xuning Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xuning Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Shaojun Tang
Hunan Institute of Microbiology, Changsha, China; Yuelushan Laboratory, Changsha, China, China
2 shared publications - Chenxia Shao
Hunan Institute of Microbiology, Changsha 410009, China
1 shared publication - Huajun Zhu
Hunan Institute of Microbiology, Changsha, China; Yuelushan Laboratory, Changsha, China, China
1 shared publication - Huajun Zhu
Hunan Institute of Microbiology, Changsha 410009, China
1 shared publication - Jieli Mo
Hunan Institute of Microbiology, Changsha 410009, China
1 shared publication - Jun Xu
Hunan Institute of Microbiology, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in Preprints.org
Genomic Basis and Immunosuppressive Mechanism of Xenorhabdus nematophila HNS01 Against the Rice Pest Chilo suppressalis
Xenorhabdus nematophila HNS01 engages in mutualistic symbiosis with nematodes of the genus Steinernema. This symbiotic complex exhibits potent insecticidal activity against Chilo suppressalis, a major biotic stress factor in rice production. To elucidate the insecticidal mechanism, we performed whole-genome sequencing and analysis of strain HNS01, and systematically evaluated its immunosuppressive effects on third-instar larvae of C. suppressalis. The genome of X. nematophila HNS01 comprises one chromosome and one plasmid, with a total size of 4,454,952 bp and a G+C content of 43.89%. Bioinformatic analysis revealed 19 secondary metabolite biosynthetic gene clusters, including those responsible for the biosynthesis of putrebactin/avaroferrin, xenematide, odilorhabdins, and xenocoumacin I/Ⅱ, as well as multiple putative protein-encoding genes that constitute the PirAB, Xpt, GroEL, and MCF toxins. Injection of strain HNS01 into third-instar larvae reduced total hemocyte counts to 7% of the initial level by 98 h, suppressed phenoloxidase and secreted phospholipase A₂ activities, and completely inhibited hemolymph melanization. Transcriptomic analysis of moribund larvae indicated that differentially expressed genes were significantly enriched in proteolysis, redox processes, cuticle structure, and fatty acid degradation pathways. Notably, genes encoding antimicrobial peptides (Cecropin, Attacin, Lebocin, and Gloverin) and serine protease inhibitors were upregulated, whereas genes encoding 5-aminoimidazole ribonucleotide carboxylase and carbon–nitrogen hydrolase were downregulated. These findings demonstrate that X. nematophila HNS01 disables host immunity through hemocyte depletion, interference with the eicosanoid pathway, and metabolic disruption, ultimately causing larval death. This study provides genomic and mechanistic insights that support X. nematophila HNS01 as a promising biocontrol agent for managing pest stress caused by C. suppressalis and improving rice stress resistance.
- 29 October 2026
- Published by MDPI AG in Preprints.org
Open AccessGenomic Basis and Immunosuppressive Mechanism of Xenorhabdus nematophila HNS01 Against the Rice Pest Chilo suppressalis
Xenorhabdus nematophila HNS01 engages in mutualistic symbiosis with nematodes of the genus Steinernema. This symbiotic complex exhibits potent insecticidal activity against Chilo suppressalis, a major biotic stress factor in rice production. To elucidate the insecticidal mechanism, we performed whole-genome sequencing and analysis of strain HNS01, and systematically evaluated its immunosuppressive effects on third-instar larvae of C. suppressalis. The genome of X. nematophila HNS01 comprises one chromosome and one plasmid, with a total size of 4,454,952 bp and a G+C content of 43.89%. Bioinformatic analysis revealed 19 secondary metabolite biosynthetic gene clusters, including those responsible for the biosynthesis of putrebactin/avaroferrin, xenematide, odilorhabdins, and xenocoumacin I/Ⅱ, as well as multiple putative protein-encoding genes that constitute the PirAB, Xpt, GroEL, and MCF toxins. Injection of strain HNS01 into third-instar larvae reduced total hemocyte counts to 7% of the initial level by 98 h, suppressed phenoloxidase and secreted phospholipase A₂ activities, and completely inhibited hemolymph melanization. Transcriptomic analysis of moribund larvae indicated that differentially expressed genes were significantly enriched in proteolysis, redox processes, cuticle structure, and fatty acid degradation pathways. Notably, genes encoding antimicrobial peptides (Cecropin, Attacin, Lebocin, and Gloverin) and serine protease inhibitors were upregulated, whereas genes encoding 5-aminoimidazole ribonucleotide carboxylase and carbon–nitrogen hydrolase were downregulated. These findings demonstrate that X. nematophila HNS01 disables host immunity through hemocyte depletion, interference with the eicosanoid pathway, and metabolic disruption, ultimately causing larval death. This study provides genomic and mechanistic insights that support X. nematophila HNS01 as a promising biocontrol agent for managing pest stress caused by C. suppressalis and improving rice stress resistance.
- Open Access
Inocutis levis Mycelial Extract WYS Exerts Anti-Proliferative and Pro-Apoptotic Effects on MCF-7 Cells via EGFR/MEK/ERK Modulation and G2/M Arrest
Inocutis levis (I. levis) is a rare edible and medicinal macrofungus with a traditional history of consumption as a dietary supplement and functional food raw material. However, the material basis and molecular mechanisms underlying its anti-breast cancer activity remain unclear. The present work aimed to systematically investigate the anti-proliferative activity of WYS, an active mycelial fraction isolated from I. levis, against MCF-7 breast cancer cells and to explore its underlying mechanisms. Firstly, 152 metabolites were putatively annotated in the WYS fraction via ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) combined with database matching. Through an integrated strategy combining network pharmacology and multi-algorithm machine learning screening, four core metabolites (dihydroartemisinin, cortisol, cinnamic acid, and guanosine) and five hub targets (CDK1, EGFR, TOP2A, FGF2, and KIT) were prioritized. Furthermore, 100 ns molecular dynamics simulations and molecular docking predicted favorable binding affinities between the core metabolites and their cognate target proteins and predicted that the anti-breast cancer effect of WYS may be associated with the regulation of cell cycle progression, mitochondrial apoptosis, and the MAPK signaling pathway. Subsequent in vitro functional assays validated that WYS inhibited the proliferation of MCF-7 cells in both dose- and time-dependent fashions, triggered G2/M phase arrest and intrinsic mitochondrial apoptosis, and inhibited the EGFR/MEK/ERK signaling axis, exhibiting limited cytotoxicity toward normal HUVEC cells. In vivo, WYS dose-dependently attenuated xenograft tumor growth, and its modulatory effects on cell cycle, apoptosis, and related signaling pathways were consistent with the in vitro observations. This study provides the first evidence that I. levis mycelial fraction WYS modulates EGFR/MEK/ERK-related signaling and induces G2/M cell cycle arrest, thereby exerting anti-proliferative and pro-apoptotic effects on MCF-7 breast cancer cells, providing a scientific basis for further investigation of I. levis as a functional food.
Open AccessInocutis levis Mycelial Extract WYS Exerts Anti-Proliferative and Pro-Apoptotic Effects on MCF-7 Cells via EGFR/MEK/ERK Modulation and G2/M Arrest
Inocutis levis (I. levis) is a rare edible and medicinal macrofungus with a traditional history of consumption as a dietary supplement and functional food raw material. However, the material basis and molecular mechanisms underlying its anti-breast cancer activity remain unclear. The present work aimed to systematically investigate the anti-proliferative activity of WYS, an active mycelial fraction isolated from I. levis, against MCF-7 breast cancer cells and to explore its underlying mechanisms. Firstly, 152 metabolites were putatively annotated in the WYS fraction via ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) combined with database matching. Through an integrated strategy combining network pharmacology and multi-algorithm machine learning screening, four core metabolites (dihydroartemisinin, cortisol, cinnamic acid, and guanosine) and five hub targets (CDK1, EGFR, TOP2A, FGF2, and KIT) were prioritized. Furthermore, 100 ns molecular dynamics simulations and molecular docking predicted favorable binding affinities between the core metabolites and their cognate target proteins and predicted that the anti-breast cancer effect of WYS may be associated with the regulation of cell cycle progression, mitochondrial apoptosis, and the MAPK signaling pathway. Subsequent in vitro functional assays validated that WYS inhibited the proliferation of MCF-7 cells in both dose- and time-dependent fashions, triggered G2/M phase arrest and intrinsic mitochondrial apoptosis, and inhibited the EGFR/MEK/ERK signaling axis, exhibiting limited cytotoxicity toward normal HUVEC cells. In vivo, WYS dose-dependently attenuated xenograft tumor growth, and its modulatory effects on cell cycle, apoptosis, and related signaling pathways were consistent with the in vitro observations. This study provides the first evidence that I. levis mycelial fraction WYS modulates EGFR/MEK/ERK-related signaling and induces G2/M cell cycle arrest, thereby exerting anti-proliferative and pro-apoptotic effects on MCF-7 breast cancer cells, providing a scientific basis for further investigation of I. levis as a functional food.